Alendronate 70 mg Once Weekly and alendronate 10 mg Once Daily preference study in postmenopausal women with osteoporosis.

被引：0
|
作者：
Palmisano, J
Lewiecki, EM
Rosen, C
Bockman, RS
Vanaman, LK
Smith, M
Wang, L
Yates, J
机构：
[1] Merck & Co Inc, W Point, PA USA
[2] New Mexico Clin Res & Osteoporosis Ctr, Albuquerque, NM USA
[3] Maine Ctr Osteoporosis, Bangor, ME USA
[4] Hosp Special Surg, New York, NY 10021 USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2001年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S404 / S404
页数：1
相关论文
共 50 条
  • [1] Preference study of alendronate 70 mg once weekly and alendronate 10 mg once daily in postmenopausal women with osteoporosis.
    Palmisano, J
    Lewiecki, EM
    Rosen, C
    Bockman, RS
    Vanaman, LK
    Smith, ME
    Wang, L
    Yates, J
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2002, 50 (04) : S64 - S64
  • [2] Preference study of alendronate 70 mg once weekly and alendronate 10 mg once daily in postmenopausal women with osteoporosis
    Palmisano, J
    Lewiecki, EM
    Rosen, C
    Bockman, RS
    Vanaman, LK
    Smith, ME
    Wang, L
    Thompson, D
    Yates, J
    OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S43 - S44
  • [3] Preference study of alendronate 70 mg once weekly and alendronate 10 mg once daily in postmenopausal women with osteoporosis
    Palmisano, J
    Melton, M
    Lewiecki, EM
    Rosen, R
    Bockman, RS
    Dinh, AC
    Smith, ME
    Wang, L
    Keene, W
    OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S36 - S36
  • [4] Alendronate 70 mg once weekly is therapeutically equivalent to alendronate 10 mg daily
    Tonino, R
    Crepaldi, G
    Schnitzer, T
    Smith, I
    Marcus, R
    Gopalakrishnan, G
    Greenwald, M
    Kiel, D
    Lipschitz, S
    Foldes, J
    Orloff, J
    Santora, A
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2000, 48 (08) : S6 - S6
  • [5] Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis
    Schnitzer, T
    Bone, HG
    Crepaldi, G
    Adami, S
    McClung, M
    Kiel, D
    Felsenberg, D
    Recker, RR
    Tonino, RP
    Roux, C
    Pinchera, A
    Foldes, AJ
    Greenspan, SL
    Levine, MA
    Emkey, R
    Santora, AC
    Kaur, A
    Thompson, DE
    Yates, J
    Orloff, JJ
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2000, 12 (01) : 1 - 12
  • [6] Once-weekly alendronate 70 mg and raloxifene 60 mg daily in the treatment of postmenopausal osteoporosis
    Luckey, M
    Kagan, R
    Greenspan, S
    Bone, H
    Kiel, RDP
    Simon, J
    Sackarowitz, J
    Palmisano, J
    Chen, E
    Petruschke, RA
    de Papp, AE
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2004, 11 (04): : 405 - 415
  • [7] Two year results of once-weekly administration of alendronate 70 mg for the treatment of postmenopausal osteoporosis.
    Rizzoli, R
    Roux, C
    Greenspan, S
    Bone, H
    Schnitzer, T
    Watts, N
    Adami, S
    Uebelhart, B
    Peverly, C
    Kaur, A
    Wu, M
    Orloff, J
    Santora, A
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S527 - S527
  • [8] Alendronate 70 mg once weekly vs. placebo: Tolerability study in patients with osteoporosis.
    Greenspan, SL
    Field-Munves, EM
    Tonino, RP
    Mako, B
    Smith, ME
    Yates, J
    Palmisano, J
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S405 - S405
  • [9] Alendronate 70 mg once weekly vs. placebo: Tolerability study in patients with osteoporosis.
    Palmisano, J
    Melton, M
    Greenspan, SL
    Field-Munves, EM
    Tonino, RP
    Dinh, AC
    Smith, ME
    Wang, L
    Keene, W
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2002, 50 (04) : S24 - S24
  • [10] Patient preference for once-weekly alendronate 70 mg versus once-daily alendronate 10 mg: A multicenter, randomized, open-label, crossover study
    Simon, JA
    Lewiecki, EM
    Smith, ME
    Petruschke, RA
    Wang, LX
    Palmisano, JJ
    CLINICAL THERAPEUTICS, 2002, 24 (11) : 1871 - 1886
12345